TORONTO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for the fiscal third quarter ended December 31, 2021, after market close on Tuesday, February 15, 2022. The Company will conduct a conference call and…


Previous articlePsychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes
Next articleSmall Pharma Reports Fiscal Third Quarter 2021 Highlights